「ceoメッセージ」の検索結果
77件：26～30件目を表示
-
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO EXα Works on unbearable eye itching due to pollens and other
https://www.senju.co.jp/english/products/apex.html -
千寿制药的沿革和历程 | 关于千寿 | 千寿制药株式会社
1947年 4月 都築博 (CEO) 于大阪市天王寺区创建公司，启动资本为195,000日元。 7月 用于治疗中性粒细胞减少的注射液"PANILTIN"上市。 1949年 2月 谷村霊真就任总裁。 6月 公司总部迁至大阪市西区。 9月 公司总部迁至大阪市东区。生产工厂迁至兵库县芦屋市。 1951年 6月 与武田药品工业株式会社达成协议，由其独家分销千寿的产品。 1955年 12
https://www.senju.co.jp/chinese/about/history.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye
http://www.senju.co.jp/english/rd/pipeline.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
http://www.senju.co.jp/english/rd/ -
NewMytear CL Ice Refresh | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines New Mytear® CL Ice Refresh Nice and comfortable feeling lasting a long time *Powerfully cool CHARACTERISTICS This medicine can be used while wearing all types of contact lense
http://www.senju.co.jp/english/products/mytearir.html